期刊文献+

30例硬皮病临床治疗体会

The 30 Cases of Scleroderma Clinical Treatment Experience
下载PDF
导出
摘要 目的:探讨硬皮病的临床治疗方案。方法选取2010年1月~2014年3月收治的硬皮病患者30例临床治疗方法资料进行分析。结果本组收治的硬皮病患者30例,显效13例,有效13例,无效4例,总有效率86.66%。结论对局限性硬皮病、系统性硬皮病患者,避免受凉,不能吸烟。甾体类抗炎药能减轻自身免疫反应,治疗后症状可停止发展或缓解。 Objective To explore the clinical treatment of scleroderma. Methods To analysis the 30 patients’cases in scleroderma clinical which were chosen from January 2010 to March 2014. Results 30 cases scleroderma patients,13 cases were markedly effective,13 cases were effective,4 cases were invalid, the total efficiency was 86.66%. Conclusion To avoid cold and no smoke on localized scleroderma and systemic scleroderma patients. Steroidal anti-inflammatory drugs can reduce the autoimmune reaction,after the treatment,the symptoms can stop the development or ease.
出处 《中国卫生标准管理》 2015年第9期190-191,共2页 China Health Standard Management
关键词 硬皮病 抗感染 替代疗法 免疫增加疗法 Scleroderma Anti infection Replacement therapy Increased immune therapy
  • 相关文献

参考文献3

二级参考文献21

  • 1张凤山,结缔组织病,1982年,230页 被引量:1
  • 2Allcock R J, Forrest I, Corris PA, et al. A study of the prevalence of systemic sclerosis in northeast England [J]. Rheumatology, 2004, 43 (5) :596-602. 被引量:1
  • 3Tan FK, Arnett FC. Genetic factors in the etiology of systemic sclerosis and Raynaud phenomenon [ J ]. Curr Opin Rheumatol, 2000, 12 (6) : 511-519. 被引量:1
  • 4Jacobsen S, Halberg P, Ullman S. Mortality and causes of death of 344- Danish patients with systemic sclerosis (scleroderma) [J]. BrJ Rheumatol, 1998,37(7) : 750-755. 被引量:1
  • 5Lekakis J, Mavrikakis M, Papamicheal C, et al. Short-termestrogen administration improves abnormal endothelial functionin women with systemic sclerosis and Raynaud' s phenomenon[J]. Am Heart J, 1998,136 (5) :905-912. 被引量:1
  • 6Choi JJ, Min DJ, Cho ML, et al. Elevated vascular endothelial growth factor in systemic sclerosis [ J ]. J Rheumatol, 2003,30(7) : 1529-1533. 被引量:1
  • 7Takagi K, Kawaguchi Y, Hara M, et al. Serum nitric oxide(NO) levels in systemic sclerosis patlents:correlatlon between NO levels and clinical features[J] .Clin Exp Imrnunol,2003,134(3):538-544. 被引量:1
  • 8Young-Min SA, Beeton C, Laughton R, et al. Serum TMP-1, TMP-2 and MMP-1 in patients with systemic sclerosis, primary Raynaud's phenomenon and in normal controls [ J]. Ann Rheum Dis, 2001,60(9):846- 851. 被引量:1
  • 9Susol E, Rands AL, Herrick A, et al. Association of markers for TGF- beta3, TGFbeta2 and TMP1 with systemic sclerosis [ J ]. Heumatology (Oxford) ,2000,39(12) : 1332-1336. 被引量:1
  • 10Yamane K, Ihn H, Kubo M, et al. Increased transcriptional activities of transforming growth factor beta receptors in sclerederma fibroblasts[ J]. Arthritis Rheum ,2002,46(9) :2421-2428. 被引量:1

共引文献48

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部